Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

126,358 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Effect of anti-DR5 and chemotherapy on basal-like breast cancer.
Oliver PG, LoBuglio AF, Zhou T, Forero A, Kim H, Zinn KR, Zhai G, Li Y, Lee CH, Buchsbaum DJ. Oliver PG, et al. Breast Cancer Res Treat. 2012 Jun;133(2):417-26. doi: 10.1007/s10549-011-1755-0. Epub 2011 Sep 7. Breast Cancer Res Treat. 2012. PMID: 21901385 Free PMC article.
Mechanisms of drug sensitization to TRA-8, an agonistic death receptor 5 antibody, involve modulation of the intrinsic apoptotic pathway in human breast cancer cells.
Amm HM, Zhou T, Steg AD, Kuo H, Li Y, Buchsbaum DJ. Amm HM, et al. Mol Cancer Res. 2011 Apr;9(4):403-17. doi: 10.1158/1541-7786.MCR-10-0133. Epub 2011 Feb 25. Mol Cancer Res. 2011. PMID: 21357440 Free PMC article.
Combined modality therapy with TRAIL or agonistic death receptor antibodies.
Amm HM, Oliver PG, Lee CH, Li Y, Buchsbaum DJ. Amm HM, et al. Cancer Biol Ther. 2011 Mar 1;11(5):431-49. doi: 10.4161/cbt.11.5.14671. Epub 2011 Mar 1. Cancer Biol Ther. 2011. PMID: 21263219 Free PMC article. Review.
Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity.
Li N, Lee K, Xi Y, Zhu B, Gary BD, Ramírez-Alcántara V, Gurpinar E, Canzoneri JC, Fajardo A, Sigler S, Piazza JT, Chen X, Andrews J, Thomas M, Lu W, Li Y, Laan DJ, Moyer MP, Russo S, Eberhardt BT, Yet L, Keeton AB, Grizzle WE, Piazza GA. Li N, et al. Oncogene. 2015 Mar 19;34(12):1499-509. doi: 10.1038/onc.2014.94. Epub 2014 Apr 7. Oncogene. 2015. PMID: 24704829 Free PMC article.
Basal-like breast cancer stem cells are sensitive to anti-DR5 mediated cytotoxicity.
Londoño-Joshi AI, Oliver PG, Li Y, Lee CH, Forero-Torres A, LoBuglio AF, Buchsbaum DJ. Londoño-Joshi AI, et al. Breast Cancer Res Treat. 2012 Jun;133(2):437-45. doi: 10.1007/s10549-011-1763-0. Epub 2011 Sep 14. Breast Cancer Res Treat. 2012. PMID: 21915634 Free PMC article.
Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
Qin H, Buckley JA, Li X, Liu Y, Fox TH 3rd, Meares GP, Yu H, Yan Z, Harms AS, Li Y, Standaert DG, Benveniste EN. Qin H, et al. J Neurosci. 2016 May 4;36(18):5144-59. doi: 10.1523/JNEUROSCI.4658-15.2016. J Neurosci. 2016. PMID: 27147665 Free PMC article.
Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer.
Forero-Torres A, Saleh MN, Galleshaw JA, Jones CF, Shah JJ, Percent IJ, Nabell LM, Carpenter JT, Falkson CI, Krontiras H, Urist MM, Bland KI, De Los Santos JF, Meredith RF, Caterinicchia V, Bernreuter WK, O'Malley JP, Li Y, LoBuglio AF. Forero-Torres A, et al. Clin Breast Cancer. 2010 Aug 1;10(4):275-80. doi: 10.3816/CBC.2010.n.035. Clin Breast Cancer. 2010. PMID: 20705559 Free PMC article. Clinical Trial.
Prognostic factors in patients with metastatic breast cancer at the time of diagnosis.
Ren Z, Li Y, Hameed O, Siegal GP, Wei S. Ren Z, et al. Pathol Res Pract. 2014 May;210(5):301-6. doi: 10.1016/j.prp.2014.01.008. Epub 2014 Feb 12. Pathol Res Pract. 2014. PMID: 24635972
DeltaF508 CFTR processing correction and activity in polarized airway and non-airway cell monolayers.
Rowe SM, Pyle LC, Jurkevante A, Varga K, Collawn J, Sloane PA, Woodworth B, Mazur M, Fulton J, Fan L, Li Y, Fortenberry J, Sorscher EJ, Clancy JP. Rowe SM, et al. Pulm Pharmacol Ther. 2010 Aug;23(4):268-78. doi: 10.1016/j.pupt.2010.02.001. Epub 2010 Mar 10. Pulm Pharmacol Ther. 2010. PMID: 20226262 Free PMC article.
126,358 results
Jump to page